| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136648 Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 05/28/2009 | US20090136575 Protein Formulation |
| 05/28/2009 | US20090136565 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R |
| 05/28/2009 | US20090136557 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 05/28/2009 | US20090136553 Triggerably dissolvable hollow fibers for controlled delivery |
| 05/28/2009 | US20090136548 Multiple antigenic peptides immunogenic against streptococcus pneumonia |
| 05/28/2009 | US20090136529 Compositions And Methods For Treatment, Research And Therapeutic Applications For Malaria |
| 05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
| 05/28/2009 | US20090136520 Mitochondrial localization of muc1 |
| 05/28/2009 | US20090136519 Tissue Protective Cytokine Receptor Complex, Assays for Identifying Tissue Protective Compounds and Uses Thereof |
| 05/28/2009 | US20090136518 Compositions and methods to reduce mutagenesis |
| 05/28/2009 | US20090136512 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136505 Intranasal Administration of Active Agents to the Central Nervous System |
| 05/28/2009 | US20090136498 Method for Manufacturing Recombinant Polyclonal Proteins |
| 05/28/2009 | US20090136497 Methods for inhibiting cutaneous inflammation and hyperpigmentation |
| 05/28/2009 | US20090136493 Modified fusion molecules for treatment of allergic disease |
| 05/28/2009 | US20090136488 Inhibition of cancer metastasis |
| 05/28/2009 | US20090136482 Drug target protein and target gene, and screening method |
| 05/28/2009 | US20090136481 Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting) |
| 05/28/2009 | US20090136478 Methods for using enzymes to disintegrate cancerous tumors in vivo |
| 05/28/2009 | US20090136477 Methods of generating and screening for proteases with altered specificity |
| 05/28/2009 | US20090136476 Arabinofuranosidases |
| 05/28/2009 | US20090136475 Immunokinases |
| 05/28/2009 | US20090136474 Stabilized Protease Composition |
| 05/28/2009 | US20090136472 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |
| 05/28/2009 | US20090136454 Anti-inflammatory activity from lactic acid bacteria |
| 05/28/2009 | US20090136453 Methods for treating pain |
| 05/28/2009 | US20090136450 Therapy for neurological diseases |
| 05/28/2009 | US20090136449 Tetracyclic Indole Derivatives as Antiviral Agents |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | US20090136447 Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor |
| 05/28/2009 | US20090136446 Induction of regulatory t cell-resistant helper cd4+ t cells |
| 05/28/2009 | US20090136445 Sustained release eye drop formulations |
| 05/28/2009 | US20090136444 molecule and chimeric molecules thereof |
| 05/28/2009 | US20090136438 Photo-protective dermatological formulations and methods of using the same |
| 05/28/2009 | US20090136433 Use of Hydrophobin-Polypeptides and Conjugates From Hydrophobin-Polypeptides Having Active and Effect Agents and the Production Thereof and Use Thereof In the Cosmetic Industry |
| 05/28/2009 | US20090136427 LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 05/28/2009 | US20090136421 PAI-2 conjugates for the treatment and imaging of cancer |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | US20090136418 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | CA2706882A1 Bone morphogenic protein binding peptide |
| 05/28/2009 | CA2706534A1 Improved cytokine design |
| 05/28/2009 | CA2706467A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 05/28/2009 | CA2706404A1 Preparation for body surface application and preparation for body suface application-holding sheet |
| 05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
| 05/28/2009 | CA2705694A1 Inhibitors of malt1 proteolytic activity and uses thereof |
| 05/28/2009 | CA2705603A1 Variants of c-type natriuretic peptide |
| 05/28/2009 | CA2705588A1 System for delivery into a xcr1 positive cell and uses thereof |
| 05/28/2009 | CA2703891A1 Compositions for reducing oxidative stress and uses thereof |
| 05/28/2009 | CA2703830A1 Modified insulin polypeptides and their uses |
| 05/27/2009 | EP2062977A1 Fucosyltransferase-gen |
| 05/27/2009 | EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062598A1 Gel type enteric nutrient |
| 05/27/2009 | EP2062593A2 Method for producing preparation containing bioactive peptide |
| 05/27/2009 | EP2062592A1 System for delivery into a XCR1 positive cell and uses thereof |
| 05/27/2009 | EP2062591A1 CACNA1E in cancer diagnosis detection and treatment |
| 05/27/2009 | EP2062590A1 Peptide derived from Hepatitis C virus |
| 05/27/2009 | EP2062589A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 05/27/2009 | EP2061886A1 Small cationic antimicrobial peptides |
| 05/27/2009 | EP2061805A1 Recombinant hcv e2 glycoprotein |
| 05/27/2009 | EP2061802A1 Process for the purification of fc-fusion proteins |
| 05/27/2009 | EP2061515A2 Long lasting drug formulations |
| 05/27/2009 | EP2061503A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 05/27/2009 | EP2061501A2 Method of treating respiratory disorders |
| 05/27/2009 | EP2061500A2 Pharmaceutical and sunscreen compositions comprising caspase-14 |
| 05/27/2009 | EP2061499A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 05/27/2009 | EP2061497A1 Compositions and methods for treatment of chronic fatigue syndrome and neurodegenerative diseases |
| 05/27/2009 | EP2061496A2 Methods of using il-31 to treat airway hyper-responsiveness and asthma |
| 05/27/2009 | EP2061495A2 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 05/27/2009 | EP2061494A1 Regulation of expression of p140cap protein in tumors |
| 05/27/2009 | EP2061493A1 Compositions to reduce or prevent skin cancer |
| 05/27/2009 | EP2061492A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 05/27/2009 | EP2061491A2 Methods and compositions for conserving and/or preparing an organ or tissue for transplant |
| 05/27/2009 | EP2061490A1 Modulators of candida hyphal morphogenesis and uses thereof |
| 05/27/2009 | EP2061489A2 High affinity ephb receptor binding compounds and methods of use thereof |
| 05/27/2009 | EP2061488A2 Selectively targeted antimicrobial peptides and the use thereof |
| 05/27/2009 | EP2061487A2 Modifications of cupredoxin derived peptides and methods of use thereof |
| 05/27/2009 | EP2061486A2 Methods and compositions for sealing and adhering biological tissues and medical uses thereof |
| 05/27/2009 | EP2061485A1 Method of treating peripheral nerve disorders |
| 05/27/2009 | EP2061481A2 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 05/27/2009 | EP2061313A2 Products and methods using soy peptides to lower total and ldl cholesterol levels |
| 05/27/2009 | EP1903874A4 Aav vectors encoding superoxide dismutase |
| 05/27/2009 | EP1740173A4 Azabicyclo-octane inhibitors of iap |
| 05/27/2009 | EP1684720B1 Introducing aerosol into a ventilator circuit |
| 05/27/2009 | EP1644028B1 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 05/27/2009 | EP1558643B1 T cell receptor display |
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |